Visual field defect associated with vigabatrin. Method of estimating prevalence was inappropriate.
Manuchehri
K
K
D000927:Anticonvulsants / Q000009:adverse effects*; D006801:Humans; D015995:Prevalence; D020888:Vigabatrin / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced*; D014794:Visual Fields / Q000187:drug effects
D000927:Anticonvulsants; D020888:Vigabatrin